- Research works
- 15 ▼ 80% vs 2013–17
- Citations
- 981 67.1 per fractional work
- Top-10% rate
- 25.6% record average 16.5%
- Open access
- 54% world 28%
Not ranked overall: Neurotune (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Neurotune (Switzerland) publish most on?
By volume in 2022–2025: Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Cancer-related cognitive impairment studies and Parkinson's Disease Mechanisms and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Dementia and Cognitive Impairment Research Psychiatry and Mental health 0 works
- 2 Alzheimer's disease research and treatments Physiology 0 works
- 3 Cancer-related cognitive impairment studies Pulmonary and Respiratory Medicine 0 works
- 4 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
- 5 Functional Brain Connectivity Studies Cognitive Neuroscience 0 works
- 6 Lanthanide and Transition Metal Complexes Materials Chemistry 0 works
- 7 Advanced MRI Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
- 8 Prion Diseases and Protein Misfolding Molecular Biology 0 works
- 9 Adenosine and Purinergic Signaling Physiology 0 works
- 10 Amyotrophic Lateral Sclerosis Research Neurology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Neurotune (Switzerland)'s research output changed?
Output in 2018–2022 was 80% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Schlieren
- Spital Limmattal
- Cell Medica (Switzerland)
- Biognosys (Switzerland)
- Molecular Partners (Switzerland)
- Kuros Biosciences (Switzerland)
- Exalos (Switzerland)
- Foundation for People with Rare Diseases
- Arcadis (Switzerland)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.